Congenital and Acquired Valvular Heart Disease in Pregnancy
- 440 Downloads
Purpose of Review
The number of pregnancies complicated by valvular heart disease is increasing. This review describes the hemodynamic effects of clinically important valvular abnormalities during pregnancy and reviews current guideline-driven management strategies.
Valvular heart disease in women of childbearing age is most commonly caused by congenital abnormalities and rheumatic heart disease. Regurgitant lesions are well tolerated, while stenotic lesions are associated with a higher risk of pregnancy-related complications. Management of symptomatic disease during pregnancy is primarily medical, with percutaneous interventions considered for refractory symptoms.
Most guidelines addressing the management of valvular heart disease during pregnancy are based on case reports and observational studies. Additional investigation is required to further advance the care of this growing patient population.
KeywordsValvular heart disease Structural heart disease Congenital heart disease Rheumatic heart disease Pregnancy
Compliance with Ethical Standards
Conflict of Interest
Sarah A. Goldstein and Cary C. Ward declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 2.Gatzoulis, Michael A., et al. Diagnosis and Management of Adult Congenital Heart Disease. 2nd Ed, Elsevier, 2011.Google Scholar
- 9.Elkayam U, et al. High-risk cardiac disease in pregnancy: Part II. J Am Coll Cardiol. 2016;68(5):502-516.Google Scholar
- 14.• Balci A, et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart. 2014; doi: 10.1136/heartjnl-2014-305597. Excellent analysis of the risk models that inform pre-pregnancy counseling.
- 18.Reimold SC, Rutherford JD. Valvular heart disease in pregnancy. N Engl J Med. 2003;349(1):52–9.Google Scholar
- 29.Warnes CA, et al. ACC/AHA 2008 guidelines for the Management of Adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008;118(23):e714–833.PubMedCrossRefGoogle Scholar
- 33.• Regitz-Zagrosek V, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011; doi: 10.1093/eurheartj/ehr218. Only source of specific practice guidelines for management of cardiovascular disease and pregnancy.
- 39.Fuster V, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J. 2006;27(16):1979–2030.PubMedCrossRefGoogle Scholar
- 53.• van Hagen IM, et al. Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation. 2015;132(2):132–42. Presents newer data about management of mechanical heart valves during pregnancy and provides insight into different anticoagulation regimens. Google Scholar